“Need to Know” – Visante’s Series of Key Takeaways for HRSA Grantees

SPONSORED CONTENT by Kristin Fox-Smith and William Wood, Visante

Those of us actively engaged in the 340B Program are well aware of the scores of issues faced by participating hospitals and it’s not surprising since they account for an exceptionally large percentage of all HRSA audits. But, what about other types of Covered Entities (CEs), such as the Specialty Clinics and Grantees? These

Read More »

Tips & Tricks for Growing Your 340B Program

SPONSORED CONTENT by Lindsay Bennett, COO, Ravin Consultants

Many organizations take a siloed approach to 340B. If you’re treating your 340B program as strictly a pharmacy program, you’re probably missing out on savings. The reality is that 340B performance is inextricably linked to other areas of operations. Operational workflows, financial reporting, and human resources procedures can profoundly impact 340B savings. Ravin Consultants

Read More »

Spring Cleaning: Three Priorities for Tending to Your 340B Program

SPONSORED CONTENT by Madeline Wallack

A highly contagious novel virus, unprecedented demands on providers, new federal programs and funding, losses on preventative care and elective surgeries, and crazy supply shortages. To say that the last year has been overwhelming on 340B entities is a serious understatement.

Like any phase in life where the objective is survival, program maintenance and “busy work” falls by the wayside.  Unfortunately, 340B

Read More »

What Covered Entities Should Know About Contracting with Specialty Pharmacies

SPONSORED CONTENT

By: Diana Sierra, MPH, VP, Contract Pharmacy Partnership & RVS Operations, Sentry Data Systems

For years, covered entities generated savings from the 340B program largely by contracting with retail pharmacies. Brick-and-mortar storefronts in their local communities, many of them trailblazing independent pharmacies, provided the most benefit for covered entities in the early years of the program.

In the past five or six years,

Read More »

A Welcome Letter to the 340B Community from Tango340B

SPONSORED CONTENT

by Monte Ruder, Head of Growth at Tango340b

Introduction

Hello fellow 340B Report readers. As this is our very first publication on this forum, I would like to take a quick moment to briefly introduce my organization, Tango340B. We are a collective of mission-driven professionals, dedicated to serving organizations who provide care to vulnerable patient populations. While our array of services is continuously expanding, our central purpose is to improve access to care for the underserved, help safety-net

Read More »

Proven Strategies 340B Covered Entities Can Use to Enhance the Specialty Pharmacy Experience for Patients

SPONSORED CONTENT

By Brandon Newman, Pharm.D., MMHC, Vice President of Clinical Affairs at Trellis Rx

Delivering an excellent customer experience is crucial for 340B covered entities seeking to differentiate their in-house specialty pharmacy services from those of external specialty pharmacies. As in other industries, providing great service will boost customer satisfaction and loyalty, leading not only to better clinical results but also to stronger financial growth.

At Trellis Rx, we partner with Zitter Insights, a division of MMIT, to regularly

Read More »

Strategies for Achieving the Right Number of 340B Savings

SPONSORED CONTENT

When it comes to 340B compliance, there’s really only one number for total savings that’s right for your organization. In the popular gameshow, The Price Is Right, the objective is to get as close to the right number without going over. It’s not that different for 340B. If you go over the right number, you’re non-compliant. If you’re under the right number, you’re not optimizing your savings. So, the question is, how do you get to that right

Read More »

View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program

SPONSORED CONTENT

As 340B covered entities continue to feel the financial impact of Medicare Part B reimbursement cuts and drug manufacturer actions that limit access to 340B pricing, a new Administration and new Congress will soon be in place. What will this mean for the future of the 340B program?

Join Omnicell for a live virtual event, “View from Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program,” to hear from multiple 340B stakeholders in a lively

Read More »

Top 10 Issues to Consider in 2021

SPONSORED CONTENT by Jim Jorgenson, CEO, Visante

2020 was a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.

As always, and particularly in the face of rising challenges, we would like to thank our many clients for trusting us to support their organizations and to help them weather the storm as we head into what will hopefully be a better 2021.

As we look ahead, as

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
×